Current Drug Targets, Volume 11 - Number 1

Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

, 11(1): 1

Daoyuan Wang and Jianxing He

DOI: 10.2174/138945010790031054

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

, 11(1): 2 - 11

Krzysztof Konopa and Jacek Jassem

DOI: 10.2174/138945010790030965

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

, 11(1): 12 - 28

Elisa Giovannetti, Richard Honeywell, Axel R. Hanauske, Christina Tekle, Bart Kuenen, Jennifer Sigmond, Giuseppe Giaccone and Godefridus J. Peters

DOI: 10.2174/138945010790031009

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

, 11(1): 29 - 36

Manyin Chen, Wenlong Shao, Jianxing He and Daoyuan Wang

DOI: 10.2174/138945010790031027

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

, 11(1): 37 - 47

M. Joerger, A. Omlin, T. Cerny and M. Fruh

DOI: 10.2174/138945010790030974

Predictive Markers for Haematological Toxicity of Pemetrexed

, 11(1): 48 - 57

S. C.H. Kao, V. H. Phan and S. J. Clarke

DOI: 10.2174/138945010790031072

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

, 11(1): 58 - 60

Steven Tucker

DOI: 10.2174/138945010790031036

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

, 11(1): 61 - 66

Joanne Ngeow and Chee-Keong Toh

DOI: 10.2174/138945010790031081

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

, 11(1): 67 - 73

Timothy D. Wagner and Gary Y. Yang

DOI: 10.2174/138945010790030956

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

, 11(1): 74 - 77

Michael Duruisseaux, Jacques Cadranel, Maurice Perol and Dominique Arpin

DOI: 10.2174/138945010790031045

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

, 11(1): 78 - 84

Mark Vincent

DOI: 10.2174/138945010790030947

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

, 11(1): 85 - 94

Tianhong Li, Primo N. Lara Jr., Philip C. Mack, Roman Perez-Soler, David R. Gandara, Gert van Assche, Severine Vermeire and Paul Rutgeerts

DOI: 10.2174/138945010790030983

Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology

, 11(1): 95 - 110

B. ten Cate, M. de Bruyn, Y. Wei, E. Bremer, W. Helfrich, Marwa El Mourabet, Sandra El-Hachem, Janet R. Harrison and David G. Binion

DOI: 10.2174/138945010790031063

Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders

, 11(1): 111 - 121

M. Mancuso, D. Orsucci, L. Volpi, V. Calsolaro, G. Siciliano, Antonino Spinelli, Carmen Correale, Hajnalka Szabo and Marco Montorsi

DOI: 10.2174/138945010790031018

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

, 11(1): 122 - 135

Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis, Panagiotis Anagnostis, Dimitri P. Mikhailidis, Gionata Fiorino, Serena Rovida, Carmen Correale, Alberto Malesci and Silvio Danese

DOI: 10.2174/138945010790030992

Webmaster Contact:
Copyright © 2018 Bentham Science